文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

鸢尾素通过Nrf2/HO-1信号通路抑制铁死亡减轻脓毒症相关急性肾损伤的机制

[Mechanism of irisin in alleviating sepsis-associated acute kidney injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论小鼠实验显示鸢尾素可能通过Nrf2/HO-1通路抑制铁死亡,减轻LPS诱导的脓毒症相关急性肾损伤。

该研究将60只C57BL/6小鼠随机分为对照组、LPS组、LPS+鸢尾素组和LPS+鸢尾素+ML385(Nrf2抑制剂)组,每组15只,通过腹腔注射LPS 10 mg/kg建立脓毒症相关急性肾损伤模型。LPS+鸢尾素组在LPS前30分钟静脉注射鸢尾素1 μg/kg;LPS+鸢尾素+ML385组在LPS前60分钟腹腔注射ML385 30 mg/kg,LPS前30分钟再注射鸢尾素。与LPS组相比,LPS+鸢尾素组血肌酐、尿素氮、IL-6、TNF-α降低,肾组织GPX4、Nrf2、HO-1表达升高,ACSL4表达降低,MDA、ROS、Fe2+降低,GSH升高(均P<0.05);加入ML385后上述保护效应被逆转。作者认为鸢尾素可能通过Nrf2/HO-1信号通路抑制铁死亡,改善LPS诱导的小鼠脓毒症相关急性肾损伤。

要点

  • 小鼠腹腔注射LPS 10 mg/kg建立脓毒症相关急性肾损伤模型,LPS+鸢尾素组在LPS前30分钟静脉注射鸢尾素1 μg/kg。
  • 与LPS组相比,LPS+鸢尾素组血肌酐31.70±3.94 vs. 65.75±7.02 μmol/L、尿素氮11.03±2.25 vs. 29.23±2.58 mmol/L,均降低(P<0.05)。
  • 与LPS组相比,LPS+鸢尾素组IL-6 239.96±14.93 vs. 1 080.40±20.06 ng/L、TNF-α 105.85±14.92 vs. 299.12±19.94 ng/L,均降低(P<0.05)。
  • 与LPS组相比,LPS+鸢尾素组肾组织GPX4/GAPDH 0.68±0.07 vs. 0.49±0.03、Nrf2/Lamin B 1.03±0.04 vs. 0.82±0.06、HO-1/GAPDH 0.93±0.02 vs. 0.66±0.04升高,ACSL4/GAPDH 0.69±0.02 vs. 0.93±0.07降低(均P<0.05)。
  • 加入Nrf2抑制剂ML385后,鸢尾素对血肌酐、尿素氮、炎症因子、铁死亡指标及肾组织病理的保护作用被逆转(均P<0.05)。

适用人群与场景

  • C57BL/6小鼠,雄性未提及,共60只,每组15只。
  • 脓毒症相关急性肾损伤模型由腹腔注射LPS 10 mg/kg建立,对照组腹腔注射等量生理盐水。

处置流程与药物剂量

  • LPS+鸢尾素组:LPS注射前30分钟静脉注射鸢尾素1 μg/kg。
  • LPS+鸢尾素+ML385组:LPS注射前60分钟腹腔注射ML385 30 mg/kg,LPS注射前30分钟再静脉注射鸢尾素1 μg/kg。
  • 造模后24小时麻醉处死小鼠,取眼球血及肾组织检测。

研究设计与关键结果

  • 研究类型为动物实验,60只C57BL/6小鼠随机分为对照组、LPS组、LPS+鸢尾素组、LPS+鸢尾素+ML385组,每组15只。
  • 与LPS组相比,LPS+鸢尾素组血肌酐31.70±3.94 vs. 65.75±7.02 μmol/L、尿素氮11.03±2.25 vs. 29.23±2.58 mmol/L、IL-6 239.96±14.93 vs. 1 080.40±20.06 ng/L、TNF-α 105.85±14.92 vs. 299.12±19.94 ng/L均降低(均P<0.05);LPS+鸢尾素+ML385组上述指标高于LPS+鸢尾素组(均P<0.05)。
  • 光镜下LPS组肾小管扩张、细胞脱落、空泡化及管型形成最重,LPS+鸢尾素组最轻;电镜下LPS组线粒体肿胀、基质稀疏、嵴减少最明显,LPS+鸢尾素组仅轻度改变。
  • 与LPS组相比,LPS+鸢尾素组GPX4/GAPDH 0.68±0.07 vs. 0.49±0.03、Nrf2/Lamin B 1.03±0.04 vs. 0.82±0.06、HO-1/GAPDH 0.93±0.02 vs. 0.66±0.04升高,ACSL4/GAPDH 0.69±0.02 vs. 0.93±0.07降低(均P<0.05);LPS+鸢尾素+ML385组GPX4、Nrf2、HO-1低于LPS+鸢尾素组,ACSL4高于LPS+鸢尾素组(均P<0.05)。
  • 与LPS组相比,LPS+鸢尾素组MDA 9.35±2.07 vs. 15.65±4.03 nmol/mg、ROS相对荧光强度584.26±74.48 vs. 1 655.68±405.71、Fe2+ 9.24±3.82 vs. 26.99±7.95 nmol/mg降低,GSH 91.50±7.99 vs. 43.13±11.85 nmol/mg升高(均P<0.05);LPS+鸢尾素+ML385组MDA、ROS、Fe2+高于LPS+鸢尾素组,GSH低于LPS+鸢尾素组(均P<0.05)。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠在体实验)。
  • 作者结论:鸢尾素通过Nrf2/HO-1信号通路抑制铁死亡,改善LPS诱导的小鼠脓毒症相关急性肾损伤,提示鸢尾素可能作为脓毒症器官保护的一种潜在治疗策略。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该研究为小鼠实验,作者认为鸢尾素可能作为脓毒症器官保护的潜在治疗策略,尚未提供人体急诊或ICU应用证据。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the ameliorative effect of irisin on sepsis-associated acute kidney injury (SA-AKI) by inhibiting ferroptosis through the regulation of the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway.

METHODS: Sixty C57BL/6 mice were divided into four groups using a random number table method: control group, lipopolysaccharide (LPS) group, LPS+irisin group, and LPS+irisin+ML385 (Nrf2 inhibitor) group, with 15 mice in each group. The SA-AKI model was established by intraperitoneal injection of LPS at a dose of 10 mg/kg, while the control group received an equal volume of normal saline. In the LPS+irisin group, irisin (1 μg/kg) was intravenously injected 30 minutes prior to LPS administration. In the LPS+irisin+ML385 group, ML385 (30 mg/kg) was intraperitoneally injected 60 minutes before LPS injection, followed by irisin injection 30 minutes before LPS. All mice were anesthetized and sacrificed 24 hours after modeling. Blood samples were collected from the eyeballs for serum creatinine (SCr) and blood urea nitrogen (BUN) measurement using an automatic biochemical analyzer. Renal tissues were harvested for the following assessments: the levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured by enzyme linked immunosorbent assay (ELISA); histopathological changes were observed under light microscope after hematoxylin-eosin (HE) staining; mitochondrial morphology was observed under transmission electron microscope after uranium acetate staining; protein expressions of glutathione peroxidase 4 (GPX4), acyl-CoA synthetase long-chain family member 4 (ACSL4), Nrf2, and HO-1 were detected by Western blotting; the contents of Fe2+, malondialdehyde (MDA), reduced glutathione (GSH), and relative fluorescence intensity of reactive oxygen species (ROS) were also measured in renal tissues.

RESULTS: 1) The levels of SCr, BUN, IL-6, and TNF-α in the LPS, LPS+irisin, and LPS+irisin+ML385 groups were higher than those in the control group (all P<0.05). Compared with the LPS group, the LPS+irisin group showed decreased levels of SCr, BUN, IL-6, and TNF-α [SCr (μmol/L): 31.70±3.94 vs. 65.75±7.02, BUN (mmol/L): 11.03±2.25 vs. 29.23±2.58, IL-6 (ng/L): 239.96±14.93 vs. 1 080.40±20.06, TNF-α (ng/L): 105.85±14.92 vs. 299.12±19.94, all P<0.05]. However, the levels of these indicators in the LPS+irisin+ML385 group were higher than those in the LPS+irisin group (all P<0.05). 2) Light microscopy revealed that compared with the control group, the LPS, LPS+irisin, and LPS+irisin+ML385 groups exhibited varying degrees of renal tubular dilation, tubular cell shedding, cellular vacuolization, and intratubular cast formation, with the most severe damage observed in the LPS group and the mildest damage in the LPS+irisin group. 3) Transmission electron microscopy showed that compared with the control group, the other three groups displayed varying degrees of mitochondrial enlargement, rounding and swelling, sparse and dissolved matrix, and reduced cristae, with the most pronounced changes in the LPS group, while mitochondrial morphology was only mildly altered in the LPS+irisin group. 4) Compared with the control group, the protein expression of GPX4 was decreased, while the protein expressions of Nrf2, HO-1, and ACSL4 were increased in the LPS, LPS+irisin, and LPS+irisin+ML385 groups (all P<0.05). Compared with the LPS group, the LPS+irisin group exhibited increased expression of GPX4, Nrf2, and HO-1, and decreased expression of ACSL4 (GPX4/GAPDH: 0.68±0.07 vs. 0.49±0.03, Nrf2/Lamin B: 1.03±0.04 vs. 0.82±0.06, HO-1/GAPDH: 0.93±0.02 vs. 0.66±0.04, ACSL4/GAPDH: 0.69±0.02 vs. 0.93±0.07, all P<0.05). Compared with the LPS+irisin group, the LPS+irisin+ML385 group showed decreased expressions of GPX4, Nrf2, and HO-1, and increased expression of ACSL4 (all P<0.05). 5) Compared with the control group, the levels of MDA, ROS, and Fe2+; were increased, while the level of GSH was decreased in the LPS, LPS+irisin, and LPS+irisin+ML385 groups (all P<0.05). Compared with the LPS group, the LPS+irisin group exhibited decreased levels of MDA, ROS, and Fe2+, and increased level of GSH [MDA (nmol/mg): 9.35±2.07 vs. 15.65±4.03, ROS (relative fluorescence intensity): 584.26±74.48 vs. 1 655.68±405.71, Fe2+ (nmol/mg): 9.24±3.82 vs. 26.99±7.95, GSH (nmol/mg): 91.50±7.99 vs. 43.13±11.85, all P<0.05]. Compared with the LPS+irisin group, the LPS+irisin+ML385 group showed increased levels of MDA, ROS, and Fe2+, and decreased level of GSH (all P<0.05).

CONCLUSIONS: Irisin ameliorates LPS-induced SA-AKI in mice by inhibiting ferroptosis through the Nrf2/HO-1 signaling pathway, suggesting that irisin may serve as a potential therapeutic strategy for organ protection in sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang B, Tang Y, Wang Y, et al. [Mechanism of irisin in alleviating sepsis-associated acute kidney injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42281538. doi:10.3760/cma.j.cn121430-20250923-00491

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。